| 51 |
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 52 |
Design, synthesis, and characterization of novel 5- ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 53 |
Design, synthesis, and computational studies of novel pyrazoline-based dual EGFR/HER-2 inhibitors with apoptotic antiproliferative activity |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 54 |
Design, synthesis, and structural elucidation of ethyl 2-amino-5-oxo-4-aryl-4H-pyrano[3,2-c] quinoline-3-carboxylates as dual EGFR/HER-2 inhibitors endowed with antiproliferative activity |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 55 |
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 56 |
Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazolinebased derivatives as dual EGFR and HER-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 57 |
Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 58 |
Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole/3-cyanopyridin-2-one hybrids as dual EGFR/BRAFV600E inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 59 |
Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 60 |
Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors |
قسم الكيمياء الدوائية |
2025 |
